908 Devices (MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ Maven for automated control of glucose and lactate levels in cell cultures. The combined solution will help scientists measure process parameters in bioreactors, offering continuous, real-time analysis without the need for manual sampling.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MASS:
